Connect with us

News

Intel Invests Additional $15 Billion In Israeli Chip Facility

Intel’s huge investment comes in addition to the $10 billion already committed by the well-known processor company back in 2019.

Published

on

intel invests additional $15 billion in israeli chip facility
Intel

On Sunday, Israel’s Ministry of Finance announced that the country had reached a new agreement with processor giant Intel that will see $25 billion of investment go towards an updated chip-making facility in Kiryat Gat.

The investment adds another $15 billion on top of the $10 billion earmarked for the proposed factory back in 2019, after the global COVID pandemic delayed construction. The new facility will be significantly more advanced than in the original plans, forming part of a larger production site known as Megafab.

Intel hasn’t yet commented directly on the investment details, but a press release was quick to praise Israeli expertise: “Israel is a global center of technical talent and innovation and one of Intel’s significant global manufacturing and R&D centers. Since its establishment in 1974, Intel Israel has played a crucial role in Intel’s global success. Our intention to expand manufacturing capacity in Israel is driven by our commitment to meeting future manufacturing needs and supporting Intel’s IDM 2.0 strategy, and we appreciate the continued support of the Israeli government”.

Also Read: Dubai Hospital Delivery Drone Completes Successful First Trial

Formal approval of the new agreement is expected to happen in a few weeks as Intel ramps up its international efforts to expand worldwide production capacity. According to a press release from the Israeli finance ministry, thousands of additional technicians will be required in Kiryat Gat, with Intel offering higher wages than the industry average. Additionally, the processor company has agreed to increase its tax obligations from 5% to 7.5%. Intel aims to close the investment deal and commence plant operations by 2027, operating the complex until at least 2035.

As manufacturers like Apple opt to develop their own processor architectures, Intel increasingly needs to adapt to a changing global market worth trillions of dollars. The company’s recent investment in Israel comes shortly after announcing a $4.6 billion deal to build a chip assembly and testing facility in Warsaw, Poland, and joins existing manufacturing facilities in Ireland and Germany.

Advertisement

📢 Get Exclusive Monthly Articles, Updates & Tech Tips Right In Your Inbox!

JOIN 23K+ SUBSCRIBERS

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

News

A Three-Clinic Network Bets Dubai Is Ready For Longevity Medicine

Longevium has enlisted nearly 100 clinicians and created an AI platform in a bid to sell biological-age tracking as a medicine, not a wellness service.

Published

on

a three-clinic network bets dubai is ready for longevity medicine

Dubai has been busily creating the scaffolding for a longevity industry, including a dedicated regulatory authority and a health market deep enough to sustain it. Now the clinics are arriving.

Longevium, a longevity clinic network, has opened three locations across the city: a flagship at Triple Seven Mall on Jumeirah 3, and branches in Jumeirah Lake Towers and Jumeirah Village Circle. Together they house a multidisciplinary team of nearly 100 physicians and specialists offering what the company bills as “a measurable medical system for longevity”.

longevity dubai clinic launch

The pitch is that longevity medicine should look less like a wellness menu and more like continuous clinical care. Each patient’s biological age assessment, laboratory results, body composition, cardiovascular risk factors, metabolic markers, and lifestyle data feed into a single profile, with a proprietary AI platform helping physicians track progress and adjust protocols against the patient’s own biomarkers.

“Healthy aging must be approached clinically through diagnostics, biomarkers, physician supervision, longitudinal tracking, and protocols tailored to the individual,” said Dr. Ksenia Butova, Longevium’s founder and CEO. “Our goal is to help patients understand their health trajectory before disease develops, and then actively change that trajectory”.

The treatment list spans peptide-based protocols, exosome therapies, stem cell approaches, GLP-1 metabolic optimization, hormone balance programs, cardiovascular prevention, and regenerative aesthetics — a model built for the entrepreneurs, executives, and international patients the clinic says want measurable results rather than generic wellness. A signature offering, Longevity Day, compresses biomarker testing, ultrasound and vascular imaging, specialist consultations, IV therapy, and a personalized optimization roadmap into a single three-hour visit.

Also Read: Dubai Certifies The World’s First Purpose-Built Air Taxi Vertiport

“Here, longevity, biotechnology, AI, prevention, and regenerative medicine are converging into a single ecosystem,” said Butova. “This is why Longevium was built in Dubai, and why we believe the UAE can become a global reference point for longevity medicine”.

The emirate established the Dubai Longevity Authority in 2026 to oversee its longevity, wellness, and advanced health sectors, and the Dubai Health Authority reported insured beneficiaries exceeding 4.9 million in 2025, up around 6.5%, with insurance claims reaching approximately 49.6 million, up around 13.5%.

Continue Reading

#Trending